Cleared Traditional

K153303 - EUROIMMUN Anti-West Nile Virus ELISA (IgG) (FDA 510(k) Clearance)

Aug 2016
Decision
268d
Days
Class 2
Risk

K153303 is an FDA 510(k) clearance for the EUROIMMUN Anti-West Nile Virus ELISA (IgG). This device is classified as a Elisa, Antibody, West Nile Virus (Class II - Special Controls, product code NOP).

Submitted by Euroimmun Us, Inc. (Morris Plains, US). The FDA issued a Cleared decision on August 10, 2016, 268 days after receiving the submission on November 16, 2015.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3940. The West Nile Virus Elisa Is Intended For The Detection Of Igg And Igm Antibodies To West Nile Virus. Specimens May Be Serum Or Cerebral Spinal Fluid From Symptomatic Patients..

Submission Details

510(k) Number K153303 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 16, 2015
Decision Date August 10, 2016
Days to Decision 268 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code NOP - Elisa, Antibody, West Nile Virus
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.3940
Definition The West Nile Virus Elisa Is Intended For The Detection Of Igg And Igm Antibodies To West Nile Virus. Specimens May Be Serum Or Cerebral Spinal Fluid From Symptomatic Patients.